Anthony S. Chilton
Keine laufenden Positionen mehr
Karriereverlauf von Anthony S. Chilton
Ehemalige bekannte Positionen von Anthony S. Chilton
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| INOTIV, INC. | Direktor/Vorstandsmitglied | 14.02.2011 | 02.03.2012 |
| Corporate Officer/Principal | 01.12.2008 | 28.01.2010 | |
| Präsident | 28.01.2010 | 05.07.2012 | |
| CARDINAL HEALTH, INC. | Corporate Officer/Principal | 01.01.1998 | - |
Genmedica Therapeutics SL
 Genmedica Therapeutics SL BiotechnologyHealth Technology Genmedica Therapeutics SL engages in the research and development of new treatments for diabetes. Its has developed novel NCE-generating platform to generate dual action, small molecules that act against oxidative stress and inflammation, two specific pathways known to be critical in the root causes of the disease. The company was founded by Alec Humayun Mian and Luc Marti Clauzel on June 21, 2004 and is headquartered in Barcelona, Spain. | Corporate Officer/Principal | 22.03.2010 | - |
Ausbildung von Anthony S. Chilton
| University of East Anglia | Undergraduate Degree |
| University of Hertfordshire | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 3 |
| Vereinigtes Königreich | 3 |
| Spanien | 2 |
Operativ
| Corporate Officer/Principal | 3 |
| Director/Board Member | 1 |
| President | 1 |
Sektoral
| Consumer Services | 3 |
| Commercial Services | 2 |
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| INOTIV, INC. | Commercial Services |
| CARDINAL HEALTH, INC. | Distribution Services |
| Private Unternehmen | 1 |
|---|---|
Genmedica Therapeutics SL
Genmedica Therapeutics SL BiotechnologyHealth Technology Genmedica Therapeutics SL engages in the research and development of new treatments for diabetes. Its has developed novel NCE-generating platform to generate dual action, small molecules that act against oxidative stress and inflammation, two specific pathways known to be critical in the root causes of the disease. The company was founded by Alec Humayun Mian and Luc Marti Clauzel on June 21, 2004 and is headquartered in Barcelona, Spain. | Health Technology |
- Börse
- Insiders
- Anthony S. Chilton
- Erfahrung